Identification of a BRCA1-mRNA Splicing Complex Required for Efficient DNA Repair and Maintenance of Genomic Stability
暂无分享,去创建一个
M. Salto‐Tellez | S. McDade | D. McCance | G. Irwin | D. Richard | G. Schettino | J. Boultwood | A. Pellagatti | Julia J. Gorski | K. Savage | D. Harkin | W. McCluggage | L. Manti | E. M. Barros | Alexander J. Powell | N. Lukashchuk | W. McCluggage | D. Richard
[1] Sean R. Davis,et al. NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..
[2] A. Børresen-Dale,et al. Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.
[3] Chunaram Choudhary,et al. Proteomic investigations reveal a role for RNA processing factor THRAP3 in the DNA damage response. , 2012, Molecular cell.
[4] Frédérick A. Mallette,et al. RNF8‐ and RNF168‐dependent degradation of KDM4A/JMJD2A triggers 53BP1 recruitment to DNA damage sites , 2012, The EMBO journal.
[5] Joshua F. McMichael,et al. Clonal evolution in relapsed acute myeloid leukemia revealed by whole genome sequencing , 2011, Nature.
[6] E. Giné,et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia , 2011, Nature Genetics.
[7] S. Sugano,et al. Frequent pathway mutations of splicing machinery in myelodysplasia , 2011, Nature.
[8] S. McDade,et al. Profiling of the BRCA1 transcriptome through microarray and ChIP-chip analysis , 2011, Nucleic acids research.
[9] P. Hamilton,et al. PARP inhibition induces BAX/BAK‐independent synthetic lethality of BRCA1‐deficient non‐small cell lung cancer , 2011, The Journal of pathology.
[10] L. Corcos,et al. Cotranscriptional exon skipping in the genotoxic stress response , 2010, Nature Structural &Molecular Biology.
[11] J. Cerhan,et al. Germline Variation in Apoptosis Pathway Genes and Risk of Non–Hodgkin's Lymphoma , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[12] Manuel de la Mata,et al. DNA Damage Regulates Alternative Splicing through Inhibition of RNA Polymerase II Elongation , 2009, Cell.
[13] M. Post,et al. Essential role for Bclaf1 in lung development and immune system function , 2009, Cell Death and Differentiation.
[14] C. Bracken,et al. Regulation of cyclin D1 RNA stability by SNIP1. , 2008, Cancer research.
[15] S A Forbes,et al. The Catalogue of Somatic Mutations in Cancer (COSMIC) , 2008, Current protocols in human genetics.
[16] Henning Urlaub,et al. Protein composition of human mRNPs spliced in vitro and differential requirements for mRNP protein recruitment. , 2006, RNA.
[17] M. Durante,et al. Measurements of metaphase and interphase chromosome aberrations transmitted through early cell replication rounds in human lymphocytes exposed to low-LET protons and high-LET 12C ions. , 2006, Mutation research.
[18] M. Yaffe,et al. MDC1 Directly Binds Phosphorylated Histone H2AX to Regulate Cellular Responses to DNA Double-Strand Breaks , 2005, Cell.
[19] J. Manley,et al. BRCA1/BARD1 inhibition of mRNA 3' processing involves targeted degradation of RNA polymerase II. , 2005, Genes & development.
[20] Francisco Martinez-Murillo,et al. Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise , 2004, Nature Genetics.
[21] J. Parvin,et al. Redistribution of BRCA1 among Four Different Protein Complexes following Replication Blockage* , 2001, The Journal of Biological Chemistry.
[22] S. Elledge,et al. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. , 1999, Science.
[23] A. Krainer,et al. Role of the Modular Domains of SR Proteins in Subnuclear Localization and Alternative Splicing Specificity , 1997, The Journal of cell biology.
[24] D. Ganem,et al. Tandem array–based expression screens identify host mRNA targets of virus-encoded microRNAs , 2009, Nature Genetics.
[25] K. Savage,et al. BRCA1 and BRCA2: Role in the DNA Damage Response, Cancer Formation and Treatment , 2009 .
[26] Y. Miki,et al. Protein kinase C delta induces transcription of the TP53 tumor suppressor gene by controlling death-promoting factor Btf in the apoptotic response to DNA damage. , 2007, Molecular and cellular biology.
[27] J. Haveman,et al. Clonogenic assay of cells in vitro , 2006, Nature Protocols.
[28] A. Hollestelle,et al. BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. , 2006, Cancer research.
[29] Ming K. Lee,et al. 22 genes from chromosome 17q21: cloning, sequencing, and characterization of mutations in breast cancer families and tumors. , 1995, Genomics.